TP53 and acute myeloid leukemia: Pre-clinical studies suggested that perhaps autophagy modulators, such as chloroquine or hydroxychloroquine, could push stressed TP53 mutant AML cells toward a threshold of death or resensitize them to chemotherapy [261,262,263].